Ahad Bakhtiari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ahad Bakhtiari has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Samad Azari
Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran
13 shared publications - Masoud Behzadifar
Lorestan University of Medical Sciences
10 shared publications Masoud Behzadifar
Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
8 shared publications- Meysam Behzadifar
Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
7 shared publications Sahar Kargar
Health Equity Research Center (HERC), Tehran University of Medical Sciences (TUMS), Tehran, Iran
6 shared publicationsFereshte Karimi
Affiliation Research Center for Emergency and Disaster Resilience, Red Crescent Society of the Islamic Republic of Iran, Tehran, Iran
5 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Springer Nature in Health Research Policy and Systems
Challenges of parliamentary engagement in health policymaking in Iran: a qualitative study using Gaventa’s power cube framework
- 6 October 2026
- Published by Springer Nature in Health Research Policy and Systems
Open AccessChallenges of parliamentary engagement in health policymaking in Iran: a qualitative study using Gaventa’s power cube framework
- Open Access
- 25 August 2026
- Published by Springer Nature in Health Research Policy and Systems
- Vol. 24 (1)
Analysing the development of health technology assessment in Iran: a policy perspective based on the five control knobs framework
- 25 August 2026
- Published by Springer Nature in Health Research Policy and Systems
- Vol. 24 (1)
Open AccessAnalysing the development of health technology assessment in Iran: a policy perspective based on the five control knobs framework
- Open Access
- 21 August 2026
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 54 (1) , 170
Frontline governance: a street-level bureaucracy perspective on brucellosis control in Western Iran
- 21 August 2026
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 54 (1) , 170
Open AccessFrontline governance: a street-level bureaucracy perspective on brucellosis control in Western Iran
- 5 March 2026
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 25 (1) , 103
Innovation without inclusion? a scoping review on inequities in diabetes technology access
Purpose This study aimed to systematically map existing evidence on how emerging medical and digital technologies influence equity in diabetes prevention, diagnosis, and management. It addressed the question: How do socioeconomic, geographic, racial/ethnic, and age-related factors shape access to diabetes technologies across different populations? Methods Following the PRISMA-ScR guidelines, a comprehensive search was conducted across PubMed, Scopus, and Web of Science for studies published between 2003 and 2025. Eligible studies examined the impact of digital health, wearable, or pharmaceutical technologies on equity in diabetes care. Data were extracted and synthesized thematically across four dimensions of disparities: socioeconomic status, geography, race/ethnicity, and age/life stage. Results From 1,635 identified records, 64 studies met the inclusion criteria. Most were from high-income countries, predominantly the United States. The findings revealed consistent disparities in access to continuous glucose monitors, insulin pumps, telemedicine, and mobile health applications. Barriers included high costs, limited insurance coverage, low digital literacy, geographic inaccessibility, and provider bias. Disadvantaged, minority, rural, and older populations were most affected. Conclusion Technological innovations have advanced diabetes care, but not equitably. Without equity-focused policy and system-level interventions, digital and medical technologies risk reinforcing existing disparities. Inclusive innovation strategies are essential to ensure fair access for all populations.
- 5 March 2026
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 25 (1) , 103
Innovation without inclusion? a scoping review on inequities in diabetes technology access
Purpose This study aimed to systematically map existing evidence on how emerging medical and digital technologies influence equity in diabetes prevention, diagnosis, and management. It addressed the question: How do socioeconomic, geographic, racial/ethnic, and age-related factors shape access to diabetes technologies across different populations? Methods Following the PRISMA-ScR guidelines, a comprehensive search was conducted across PubMed, Scopus, and Web of Science for studies published between 2003 and 2025. Eligible studies examined the impact of digital health, wearable, or pharmaceutical technologies on equity in diabetes care. Data were extracted and synthesized thematically across four dimensions of disparities: socioeconomic status, geography, race/ethnicity, and age/life stage. Results From 1,635 identified records, 64 studies met the inclusion criteria. Most were from high-income countries, predominantly the United States. The findings revealed consistent disparities in access to continuous glucose monitors, insulin pumps, telemedicine, and mobile health applications. Barriers included high costs, limited insurance coverage, low digital literacy, geographic inaccessibility, and provider bias. Disadvantaged, minority, rural, and older populations were most affected. Conclusion Technological innovations have advanced diabetes care, but not equitably. Without equity-focused policy and system-level interventions, digital and medical technologies risk reinforcing existing disparities. Inclusive innovation strategies are essential to ensure fair access for all populations.
- Open Access
- 4 January 2026
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 54 (1) , 2
Strengthening brucellosis prevention and control in Iran: policy priorities informed by stakeholder networks, agenda-setting dynamics, and economic burden evidence
Brucellosis imposes persistent public health and economic burdens in Iran, yet multisectoral coordination remains limited. Drawing on three published studies, a stakeholder network analysis, a policy agenda-setting assessment, and a cost-of-illness evaluation, this correspondence synthesizes key evidence to identify structural, political, and financial barriers to effective control. Findings reveal fragmented stakeholder engagement, misalignment of problem–policy–politics streams, and a substantial proportion of affected households exposed to catastrophic health expenditure, highlighting major gaps in financial protection. The integrated evidence supports six priority actions, including establishing One Health governance, strengthening vaccination and veterinary capacity, enhancing community engagement, improving financial protection, increasing political prioritization, and expanding international collaboration. These measures are essential for sustainable brucellosis control in Iran.
- 4 January 2026
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 54 (1) , 2
Open AccessStrengthening brucellosis prevention and control in Iran: policy priorities informed by stakeholder networks, agenda-setting dynamics, and economic burden evidence
Brucellosis imposes persistent public health and economic burdens in Iran, yet multisectoral coordination remains limited. Drawing on three published studies, a stakeholder network analysis, a policy agenda-setting assessment, and a cost-of-illness evaluation, this correspondence synthesizes key evidence to identify structural, political, and financial barriers to effective control. Findings reveal fragmented stakeholder engagement, misalignment of problem–policy–politics streams, and a substantial proportion of affected households exposed to catastrophic health expenditure, highlighting major gaps in financial protection. The integrated evidence supports six priority actions, including establishing One Health governance, strengthening vaccination and veterinary capacity, enhancing community engagement, improving financial protection, increasing political prioritization, and expanding international collaboration. These measures are essential for sustainable brucellosis control in Iran.
- Open Access
- 27 November 2025
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 53 (1) , 174
The economic burden of brucellosis in Western Iran
Background: Brucellosis, a zoonotic disease caused by Brucella species, remains a major public health and economic challenge in regions dependent on livestock farming. In Iran, particularly in the western provinces, the disease imposes a heavy burden on healthcare systems and households through medical costs and productivity losses. This study quantified the economic burden of brucellosis in western Iran to inform policy and resource allocation. Methods: A cross-sectional cost-of-illness study was conducted among 427 brucellosis patients in Lorestan province . Data on direct medical costs (hospitalization, medications, diagnostics), direct non-medical costs (transportation, accommodation), and indirect costs (productivity losses) were collected using a bottom-up approach. All costs were expressed in 2024 USD, and sensitivity analyses were conducted at 0% and 5% discount rates. The catastrophic health expenditure (CHE) index was used to assess financial hardship. Results: The mean total cost per patient was 1,060 USD, with direct medical costs representing 73.6% of the total. Hospitalization was the largest component (38%), followed by surgical interventions (26%) and medications (13%). Indirect costs accounted for 18.9% of the total burden. The CHE index reached 66.3%, indicating severe financial strain for affected households. Sensitivity analyses showed notable variability in medical and non-medical cost estimates. Conclusion: Brucellosis imposes a substantial economic burden in western Iran, reflecting both healthcare and productivity losses. Effective control measures such as livestock vaccination, improved diagnosis, and expanded insurance coverage are essential to reduce financial hardship and support sustainable disease management.
- 27 November 2025
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 53 (1) , 174
Open AccessThe economic burden of brucellosis in Western Iran
Background: Brucellosis, a zoonotic disease caused by Brucella species, remains a major public health and economic challenge in regions dependent on livestock farming. In Iran, particularly in the western provinces, the disease imposes a heavy burden on healthcare systems and households through medical costs and productivity losses. This study quantified the economic burden of brucellosis in western Iran to inform policy and resource allocation. Methods: A cross-sectional cost-of-illness study was conducted among 427 brucellosis patients in Lorestan province . Data on direct medical costs (hospitalization, medications, diagnostics), direct non-medical costs (transportation, accommodation), and indirect costs (productivity losses) were collected using a bottom-up approach. All costs were expressed in 2024 USD, and sensitivity analyses were conducted at 0% and 5% discount rates. The catastrophic health expenditure (CHE) index was used to assess financial hardship. Results: The mean total cost per patient was 1,060 USD, with direct medical costs representing 73.6% of the total. Hospitalization was the largest component (38%), followed by surgical interventions (26%) and medications (13%). Indirect costs accounted for 18.9% of the total burden. The CHE index reached 66.3%, indicating severe financial strain for affected households. Sensitivity analyses showed notable variability in medical and non-medical cost estimates. Conclusion: Brucellosis imposes a substantial economic burden in western Iran, reflecting both healthcare and productivity losses. Effective control measures such as livestock vaccination, improved diagnosis, and expanded insurance coverage are essential to reduce financial hardship and support sustainable disease management.
- Open Access
- 20 April 2023
- Published by Springer Nature in Health Economics Review
- Vol. 13 (1) , 1-7
The role of Iran's context for the development of health technology assessment: challenges and solutions
Health technology assessment (HTA) is a comprehensive and structured evaluation that aims to analyze the potential impacts of health technologies, including medical devices, diagnostic tools, pharmaceuticals, and public health interventions. Its purpose is to provide policymakers with evidence-based information to inform decisions related to the utilization and implementation of these technologies. HTA allows for the comparison of various scenarios related to a technology across a wide range of factors. This can aid in the creation of an essential drug list and health benefits package that is tailored to the actual needs of the community within a given healthcare system. In the present paper, we review the role of Iran's context for the development of HTA, in terms of challenges and solutions.
- 20 April 2023
- Published by Springer Nature in Health Economics Review
- Vol. 13 (1) , 1-7
Open AccessThe role of Iran's context for the development of health technology assessment: challenges and solutions
Health technology assessment (HTA) is a comprehensive and structured evaluation that aims to analyze the potential impacts of health technologies, including medical devices, diagnostic tools, pharmaceuticals, and public health interventions. Its purpose is to provide policymakers with evidence-based information to inform decisions related to the utilization and implementation of these technologies. HTA allows for the comparison of various scenarios related to a technology across a wide range of factors. This can aid in the creation of an essential drug list and health benefits package that is tailored to the actual needs of the community within a given healthcare system. In the present paper, we review the role of Iran's context for the development of HTA, in terms of challenges and solutions.
- Open Access
- 6 May 2020
- Published by Springer Nature in International Journal for Equity in Health
- Vol. 19 (1) , 1-4
Ensuring adequate health financing to prevent and control the COVID-19 in Iran
On February 19th 2020, the Iranian Ministry of Health and Medical Education (MoHME) has announced the first 2 cases of SARS-CoV-2, a novel emerging coronavirus which causes an infection termed as COVID-19, in Qom city. As such, the Iranian government, through the establishment of the “National Headquarters for the management and control of the novel Coronavirus”, has started implementing policies and programs for the prevention and control of the virus. These measures include schools and universities closure, reduced working hours, and increased production and delivery of equipment such as masks, gloves and hygienic materials for sterile environments. The government has also made efforts to divulge high-quality information concerning the COVID-19 and to provide laboratories and hospitals with diagnostic kits and adequate resources to treat patients. However, despite such efforts, the number of cases and deaths has progressively increased with rising trends in total confirmed cases and deaths, as well as in new daily cases and deaths associated with the COVID-19. Iran is a developing country and its economic infrastructure has been hit hardly by embargo and sanctions. While developed countries have allocated appropriate funding and are responding adequately to the COVID-19 pandemics, Iran has experienced a serious surge of cases and deaths and should strive to provide additional resources to the health system to make healthcare services more accessible and to increase the fairness of that access. All relevant actors and stakeholders should work together to fight this disease.
- 6 May 2020
- Published by Springer Nature in International Journal for Equity in Health
- Vol. 19 (1) , 1-4
Open AccessEnsuring adequate health financing to prevent and control the COVID-19 in Iran
On February 19th 2020, the Iranian Ministry of Health and Medical Education (MoHME) has announced the first 2 cases of SARS-CoV-2, a novel emerging coronavirus which causes an infection termed as COVID-19, in Qom city. As such, the Iranian government, through the establishment of the “National Headquarters for the management and control of the novel Coronavirus”, has started implementing policies and programs for the prevention and control of the virus. These measures include schools and universities closure, reduced working hours, and increased production and delivery of equipment such as masks, gloves and hygienic materials for sterile environments. The government has also made efforts to divulge high-quality information concerning the COVID-19 and to provide laboratories and hospitals with diagnostic kits and adequate resources to treat patients. However, despite such efforts, the number of cases and deaths has progressively increased with rising trends in total confirmed cases and deaths, as well as in new daily cases and deaths associated with the COVID-19. Iran is a developing country and its economic infrastructure has been hit hardly by embargo and sanctions. While developed countries have allocated appropriate funding and are responding adequately to the COVID-19 pandemics, Iran has experienced a serious surge of cases and deaths and should strive to provide additional resources to the health system to make healthcare services more accessible and to increase the fairness of that access. All relevant actors and stakeholders should work together to fight this disease.
- Open Access
- 19 April 2020
- Published by Springer Nature in BMC Health Services Research
- Vol. 20 (1) , 1-8
The effect of the Iranian health transformation plan on hospitalization rate: insights from an interrupted time series analysis
Background: Healthcare policy- and decision-makers make efforts to build and maintain high-performing and effective health systems, implementing effectiveness programs and health reforms. In May 2014, the Iranian Ministry of Health and Medical Education has launched a series of ambitious reforms, known as the Health Transformation Plan (HTP). This study aimed to determine the effect of the HTP on hospitalization rate in Iranian public hospitals affiliated to the Ministry of Health and Medical Education.Methods: This study was designed as a quasi-experimental, counterfactual study utilizing the interrupted time series analysis (ITSA), comparing the trend of hospitalization rate before and after the HTP implementation in 16 hospitals in the Lorestan province. Data was collected from March 2012 to February 2019.Results: In the first month of the HTP implementation, an increase of 2.627 [95% CI: 1.62–3.63] was noted (P < 0.001). Hospitalization rate increased by 0.68 [95% CI: 0.32–0.85] after the HTP implementation compared to the first month after the launch of the HTP (P < 0.001). After the HTP implementation, monthly hospitalization rate per 1000 persons significantly increased by 0.049 [95% CI: 0.023–0.076] (P < 0.001).Conclusions: The HTP implementation has resulted in an increased hospitalization rate. Health planners should continue to further improve this service. ITSA can play a role in evaluating the impact of a given health policy.
- 19 April 2020
- Published by Springer Nature in BMC Health Services Research
- Vol. 20 (1) , 1-8
Open AccessThe effect of the Iranian health transformation plan on hospitalization rate: insights from an interrupted time series analysis
Background: Healthcare policy- and decision-makers make efforts to build and maintain high-performing and effective health systems, implementing effectiveness programs and health reforms. In May 2014, the Iranian Ministry of Health and Medical Education has launched a series of ambitious reforms, known as the Health Transformation Plan (HTP). This study aimed to determine the effect of the HTP on hospitalization rate in Iranian public hospitals affiliated to the Ministry of Health and Medical Education.Methods: This study was designed as a quasi-experimental, counterfactual study utilizing the interrupted time series analysis (ITSA), comparing the trend of hospitalization rate before and after the HTP implementation in 16 hospitals in the Lorestan province. Data was collected from March 2012 to February 2019.Results: In the first month of the HTP implementation, an increase of 2.627 [95% CI: 1.62–3.63] was noted (P < 0.001). Hospitalization rate increased by 0.68 [95% CI: 0.32–0.85] after the HTP implementation compared to the first month after the launch of the HTP (P < 0.001). After the HTP implementation, monthly hospitalization rate per 1000 persons significantly increased by 0.049 [95% CI: 0.023–0.076] (P < 0.001).Conclusions: The HTP implementation has resulted in an increased hospitalization rate. Health planners should continue to further improve this service. ITSA can play a role in evaluating the impact of a given health policy.
- Open Access
- 18 January 2019
- Published by Springer Nature in BMC Research Notes
- Vol. 12 (1) , 37
The effect of the health transformation plan on cesarean section in Iran: a systematic review of the literature
Cesarean section (CS) is one of the most common surgical procedures in the world. In developed and developing countries, CS has grown significantly over the past decades. The Iranian Ministry of Health and Medical Education has developed a health transformation plan (HTP) in order to reduce CS rate and promote vaginal delivery. This study was conducted with the aim of reviewing the results of published studies on the impact of the HTP on CS in Iran. We searched Embase, PubMed/MEDLINE, ISI/Web of Sciences, Scopus, as well as Iranian databases (MagIran, SID and Barakatkns), from May 2014 to October 2018. To assess the quality of studies, the checklist “A Cochrane Risk of Bias Assessment Tool: for Non-Randomized Studies of Interventions” was utilized. Twelve studies were selected. Seven studies reported statistically significant results, showing a positive impact of the implementation of the HTP on CS reduction. Despite the decreased CS rate in Iran after about 4 years of the implementation of this policy, the goal of a yearly reduction by 10% has not been achieved yet. Increasing access to maternity services and community-based education through mass media could help changing the attitudes of Iranian mothers towards CS.
- 18 January 2019
- Published by Springer Nature in BMC Research Notes
- Vol. 12 (1) , 37
Open AccessThe effect of the health transformation plan on cesarean section in Iran: a systematic review of the literature
Cesarean section (CS) is one of the most common surgical procedures in the world. In developed and developing countries, CS has grown significantly over the past decades. The Iranian Ministry of Health and Medical Education has developed a health transformation plan (HTP) in order to reduce CS rate and promote vaginal delivery. This study was conducted with the aim of reviewing the results of published studies on the impact of the HTP on CS in Iran. We searched Embase, PubMed/MEDLINE, ISI/Web of Sciences, Scopus, as well as Iranian databases (MagIran, SID and Barakatkns), from May 2014 to October 2018. To assess the quality of studies, the checklist “A Cochrane Risk of Bias Assessment Tool: for Non-Randomized Studies of Interventions” was utilized. Twelve studies were selected. Seven studies reported statistically significant results, showing a positive impact of the implementation of the HTP on CS reduction. Despite the decreased CS rate in Iran after about 4 years of the implementation of this policy, the goal of a yearly reduction by 10% has not been achieved yet. Increasing access to maternity services and community-based education through mass media could help changing the attitudes of Iranian mothers towards CS.